Literature DB >> 25088311

Heterozygous CLCN1 mutations can modulate phenotype in sodium channel myotonia.

A Furby1, S Vicart2, J P Camdessanché3, E Fournier4, S Chabrier5, E Lagrue6, C Paricio7, P Blondy8, R Touraine9, D Sternberg8, B Fontaine10.   

Abstract

Nondystrophic myotonias are characterized by muscle stiffness triggered by voluntary movement. They are caused by mutations in either the CLCN1 gene in myotonia congenita or in the SCN4A gene in paramyotonia congenita and sodium channel myotonias. Clinical and electrophysiological phenotypes of these disorders have been well described. No concomitant mutations in both genes have been reported yet. We report five patients from three families showing myotonia with both chloride and sodium channel mutations. Their clinical and electrophysiological phenotypes did not fit with the phenotype known to be associated with the mutation initially found in SCN4A gene, which led us to screen and find an additional mutation in CLCN1 gene. Our electrophysiological and clinical observations suggest that heterozygous CLCN1 mutations can modify the clinical and electrophysiological expression of SCN4A mutation.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CLCN1; Electromyography; Myotonia; Myotonia congenita; Nondystrophic myotonia; Paramyotonia congenita; SCN4A; Sodium channel myotonia

Mesh:

Substances:

Year:  2014        PMID: 25088311     DOI: 10.1016/j.nmd.2014.06.439

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  12 in total

1.  Translating genetic and functional data into clinical practice: a series of 223 families with myotonia.

Authors:  Karen Suetterlin; Emma Matthews; Richa Sud; Samuel McCall; Doreen Fialho; James Burge; Dipa Jayaseelan; Andrea Haworth; Mary G Sweeney; Dimitri M Kullmann; Stephanie Schorge; Michael G Hanna; Roope Männikkö
Journal:  Brain       Date:  2022-04-18       Impact factor: 15.255

2.  Coexistence of CLCN1 and SCN4A mutations in one family suffering from myotonia.

Authors:  Lorenzo Maggi; Sabrina Ravaglia; Alessandro Farinato; Raffaella Brugnoni; Concetta Altamura; Paola Imbrici; Diana Conte Camerino; Alessandro Padovani; Renato Mantegazza; Pia Bernasconi; Jean-François Desaphy; Massimiliano Filosto
Journal:  Neurogenetics       Date:  2017-10-09       Impact factor: 2.660

3.  Targeted Therapies for Skeletal Muscle Ion Channelopathies: Systematic Review and Steps Towards Precision Medicine.

Authors:  Jean-François Desaphy; Concetta Altamura; Savine Vicart; Bertrand Fontaine
Journal:  J Neuromuscul Dis       Date:  2021

4.  Multidisciplinary study of a new ClC-1 mutation causing myotonia congenita: a paradigm to understand and treat ion channelopathies.

Authors:  Paola Imbrici; Concetta Altamura; Giulia Maria Camerino; Giuseppe Felice Mangiatordi; Elena Conte; Lorenzo Maggi; Raffaella Brugnoni; Kejla Musaraj; Roberta Caloiero; Domenico Alberga; Renè Massimiliano Marsano; Giulia Ricci; Gabriele Siciliano; Orazio Nicolotti; Marina Mora; Pia Bernasconi; Jean-Francois Desaphy; Renato Mantegazza; Diana Conte Camerino
Journal:  FASEB J       Date:  2016-06-20       Impact factor: 5.191

5.  Predominantly myalgic phenotype caused by the c.3466G>A p.A1156T mutation in SCN4A gene.

Authors:  Johanna Palmio; Satu Sandell; Michael G Hanna; Roope Männikkö; Sini Penttilä; Bjarne Udd
Journal:  Neurology       Date:  2017-03-22       Impact factor: 9.910

6.  Myotonia congenita and periodic hypokalemia paralysis in a consanguineous marriage pedigree: Coexistence of a novel CLCN1 mutation and an SCN4A mutation.

Authors:  Chenyu Zhao; DongFang Tang; Hui Huang; Haiyan Tang; Yuan Yang; Min Yang; Yingying Luo; Huai Tao; Jianguang Tang; Xi Zhou; Xiaoliu Shi
Journal:  PLoS One       Date:  2020-05-14       Impact factor: 3.240

7.  Myotonia in a patient with a mutation in an S4 arginine residue associated with hypokalaemic periodic paralysis and a concomitant synonymous CLCN1 mutation.

Authors:  Michael G Thor; Vinojini Vivekanandam; Marisol Sampedro-Castañeda; S Veronica Tan; Karen Suetterlin; Richa Sud; Siobhan Durran; Stephanie Schorge; Dimitri M Kullmann; Michael G Hanna; Emma Matthews; Roope Männikkö
Journal:  Sci Rep       Date:  2019-11-26       Impact factor: 4.379

Review 8.  Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery.

Authors:  Paola Imbrici; Antonella Liantonio; Giulia M Camerino; Michela De Bellis; Claudia Camerino; Antonietta Mele; Arcangela Giustino; Sabata Pierno; Annamaria De Luca; Domenico Tricarico; Jean-Francois Desaphy; Diana Conte
Journal:  Front Pharmacol       Date:  2016-05-10       Impact factor: 5.810

Review 9.  Genetic neurological channelopathies: molecular genetics and clinical phenotypes.

Authors:  J Spillane; D M Kullmann; M G Hanna
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-11-11       Impact factor: 10.154

10.  SCN4A as modifier gene in patients with myotonic dystrophy type 2.

Authors:  Anna Binda; Laura V Renna; Francesca Bosè; Elisa Brigonzi; Annalisa Botta; Rea Valaperta; Barbara Fossati; Ilaria Rivolta; Giovanni Meola; Rosanna Cardani
Journal:  Sci Rep       Date:  2018-07-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.